Ionis Pharmaceuticals, Inc.
IONS
$72.33
-$0.01-0.01%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -119.83% | 8.45% | 286.45% | -2.90% | -1,026.51% |
| Total Depreciation and Amortization | 39.38% | -18.04% | -2.24% | -4.49% | -6.15% |
| Total Amortization of Deferred Charges | 17.56% | -1.55% | -1.50% | -1.50% | 0.60% |
| Total Other Non-Cash Items | 37.20% | -113.34% | 48.28% | -2.47% | 95.07% |
| Change in Net Operating Assets | 138.86% | 36.01% | 69.71% | 9.55% | -572.70% |
| Cash from Operations | -18.57% | -14.30% | 226.24% | -0.56% | -453.38% |
| Capital Expenditure | 16.49% | 41.81% | -97.39% | -179.92% | -3,213.19% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -524.94% | 129.12% | -256.90% | 127.10% | 440.37% |
| Cash from Investing | -714.99% | 126.80% | -292.26% | 123.98% | 355.36% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -500.95% | 14.58% | -2.56% | -7.69% | -117,123.68% |
| Issuance of Common Stock | 25,032.17% | -83.62% | -50.42% | -90.51% | -98.95% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1,440.05% | -83.63% | -51.23% | -90.67% | -208.33% |
| Foreign Exchange rate Adjustments | 91.15% | -123.43% | 2,686.96% | 303.51% | -247.27% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 136.66% | 1.05% | 160.32% | 143.90% | -296.01% |